Thursday, September 10, 2026 · Daily edition
Job-finding diagnostics, record U.S. power sales, and staged medical-AI authorisations
Today’s ledger follows Richmond Fed Economic Brief 26-27 on who accounts for the U.S. job-finding slowdown, EIA’s September Short-Term Energy Outlook printing record electricity generation and sales with data centers among the named drivers, the UK MHRA National Commission’s staged “L-plate” medical-AI authorisation blueprint, a Nature correspondence on patient rights in medical AI governance, and UNESCO’s global consultation on education in the age of AI with comments due 15 October 2026.
Richmond Fed EB 26-27: high-AI-exposure pain is sharp — less-exposed workers still drive about half the job-finding drop
What happened. Richmond Fed Economic Brief No. 26-27 (August 2026), Borovičková and Macaluso, Aggregate or Structural? Diagnosing the Rise in Unemployment, decomposes the U.S. job-finding decline from mid-2023 through March 2026. The largest within-group drop sits with strongly attached workers in high-AI-exposure occupations — but that group is small, so it explains at most about one-third of the aggregate decline. Less-exposed workers (primary and secondary attachment) account for roughly half of the decline; the largest single contribution is secondary workers in low-AI-exposure occupations. Compositional shift across groups is under 3%. Primary workers are about 55% of the population, secondary about 14%, tertiary about 31%. The authors’ bottom line: AI exposure is important but not dominant; aggregate forces remain the dominant factor. Targeted retraining for highly exposed occupations may reach an important segment without fixing most of the slowdown. Views are the authors’ and do not necessarily reflect Richmond Fed or Board policy.
What to watch. The sharpest AI-linked job-finding hit is concentrated, but most of the aggregate slowdown still lands on workers with little direct AI overlap. Keep this unemployment-outflow diagnostic separate from Atlanta Fed WP 2026-4’s executive survey, Brookings Metro’s adaptive-capacity residual, Census CES adoption packages, NY Fed firm-use shares, PwC’s job-ad barometer, and any 2026 layoff census.
Read Richmond Fed Economic Brief 26-27 →
EIA September STEO: record U.S. electricity generation in 2026 — data centers still among the sales drivers
What happened. EIA’s 9 September 2026 press release on the September Short-Term Energy Outlook projects U.S. electricity generation up 2.2% to a record 4,368 billion kWh in 2026, then up another 1.7% in 2027. Electricity sales rise to 4,135 BkWh in 2026 (almost 2% vs 2025) and 4,211 BkWh in 2027 (+2%). Drivers named on the page include data-center development and manufacturing. Despite a pause in new data-center projects in Texas, West South Central remains the largest regional contributor to sales growth. Same-release STEO detail: WSC sales 761 BkWh (2026) / 790 BkWh (2027) vs the August path of 765 / 829 (−0.5% / −4.7%). Model inputs were finalized 3 September 2026. Generation-share context (rounded): natural gas about 40% through 2025–2027; coal 17% / 16% / 14%; nuclear 18%; wind 11% / 11% / 12%; solar 7% / 8% / 9%. Companion CO2 path: about 4.9 / 4.8 / 4.8 billion metric tons across 2025, 2026, and 2027.
What to watch. Even after cutting the WSC path and after the Texas pause, EIA still prints a national electricity-sales record with data centers among the named drivers — a monthly forecast, not another decade-ahead data-centre power path. Keep it separate from IEA Electricity 2026 Demand’s U.S. data-centre share of load growth, the 4 September Texas 6% vs 14% load-growth card, AEO2026 server shares, Gartner’s global data-centre TWh path, and campus megawatt announcements.
Read the EIA September STEO press release →
UK MHRA National Commission: staged “L-plate” authorisations and lifetime monitoring for medical AI
What happened. On 10 September 2026, GOV.UK published the Independent Commission’s blueprint on regulating AI in healthcare, established by the Medicines and Healthcare products Regulatory Agency in September 2025 and led by NHS doctors. Evidence came from more than 12,000 people over a year — patients, public, clinicians, healthcare leaders, and industry. Government and MHRA will consider the advice; a formal response comes later — this is not adopted law. Locked recommendations: staged authorisations for new AI models, framed as “L-plates” (close supervision first, then fuller authorisation); continuous real-world monitoring across a device’s working life rather than a single point-in-time approval; a public search for safety information on specific AI-enabled medical devices, including adverse incidents; and stronger MHRA enforcement powers. Engagement finding on the same page: broad public support is conditional on strong safety standards, meaningful human oversight, and transparency about when and how AI is used in someone’s care.
What to watch. The UK is proposing learner-plate staged entry and lifetime safety monitoring for medical AI — with a public safety page — before any statute is written. Keep this advisory clinical-device path separate from live EU Article 50 system-transparency labels, the EU GPAI Code’s Articles 53/55 model-provider chapters, California’s transparency act, NIST AI 300-1 templates, and Canada’s transparency consultation.
Read the UK MHRA National Commission news page →
Nature correspondence: put patients at the centre of medical AI governance
What happened. Nature published an 8 September 2026 Correspondence by Shen and Yu, Put patients at the centre of medical AI governance (Nature 657, 566; DOI 10.1038/d41586-026-02796-8). The locked lede: Lam et al. classify medical AI by autonomy, automation, and operational scope (Nature 655, 1129–1132; 2026). They mention informed consent, yet the framework remains centred on allocating responsibility to clinicians, health-care organizations, device manufacturers, and regulators. Patient rights receive no systematic place in its design. This is a correspondence letter — not a patient-outcome RCT, not a diagnostic-accuracy print, and not a clearance claim.
What to watch. Governance taxonomies that sort tools and institutions can still leave patients outside the design frame — a different gap from missing AUROCs or missing outcome trials. Pair the letter with the UK Commission’s staged-authorisation and lifecycle-monitoring advice without collapsing either into a bedside approval claim.
Read the Nature correspondence →
UNESCO opens a global consultation on education in the age of AI — comments due 15 October 2026
What happened. UNESCO’s consultation page invites feedback on the discussion paper Sustaining education as a common good in the age of AI: The case for deliberative governance, plus six background papers on digital/AI sovereignty; age-appropriateness; learner safety (“safe enough to scale”); procurement; total cost of ownership; and the right to an explanation. Comments are due 15 October 2026 (window September–November 2026) to [email protected]; feedback is slated to feed policy briefs at Digital Learning Week 2027. Consultation questions name UNESCO principles of human agency, equity, inclusion, safety, and ethics. A companion ministers article from Digital Learning Week frames the common-good statement on the 2023 generative-AI guidance and 2024 AI competency frameworks and recalls the 2021 Recommendation on the Ethics of AI adopted by 194 Member States.
What to watch. The education-AI agenda is shifting from prize ceremonies and usage polls toward open governance design — age, safety, inclusion, and cost of ownership on the table before next year’s policy briefs. Keep this distinct from yesterday’s Finland/Brazil ICT Prize ceremony and from undergraduate AI-use survey packages.
Read the UNESCO education-in-the-age-of-AI consultation →
Also in today’s ledger
• Retraining only the most AI-exposed occupations would miss most of the measured job-finding slowdown in the Richmond package.
• EIA’s national sales-record monthly is not the same product as IEA’s decade-ahead U.S. data-centre growth-share card.
• WHO/ITU/WIPO GI-AI4H Hangzhou remains 16–18 September — calendar context only; results are not regulatory approval.
|